Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 2 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 2 5 IN PLASTIC CONTAINER.
DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER vs DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
The dextrose component provides osmotic pressure for peritoneal dialysis, promoting ultrafiltration of fluid and removal of solutes. Calcium and other electrolytes maintain physiologic balance.
Dianeal PD-2 with Dextrose 2.5% is a peritoneal dialysis solution that removes waste products and excess fluid from the blood via diffusion and ultrafiltration across the peritoneal membrane. Dextrose creates an osmotic gradient driving fluid removal; electrolytes (sodium, chloride, calcium, magnesium, lactate) correct electrolyte imbalances.
Intraperitoneal: Continuous ambulatory peritoneal dialysis (CAPD): 2-2.5 L per exchange, 4-5 exchanges per day; Continuous cyclic peritoneal dialysis (CCPD): 2-2.5 L per exchange, 3-5 nocturnal exchanges plus one daytime dwell.
Intraperitoneal administration: 2 to 2.5 liters per exchange, typically 4 exchanges per day, with dwell times of 4-6 hours during the day and 8-12 hours overnight. Concentration selected based on ultrafiltration needs.
None Documented
None Documented
Not applicable as a solution; glucose half-life ~20-30 min in circulation; clinical effect duration corresponds to dwell time (4-6 hours for standard exchange)
Not applicable; drug is not systemically absorbed. The peritoneal clearance of glucose follows first-order kinetics with a half-life of approximately 2-3 hours in the peritoneal cavity.
Primarily eliminated via peritoneal dialysis; glucose is metabolized systemically and excreted as CO2 and water; <5% renal excretion of metabolites
Renal: negligible; drug is not absorbed systemically. The glucose is metabolized locally in peritoneal cavity and removed with dialysate outflow.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution